The main olfactory epithelium (MOE) of an adult mouse harbors a few million mature olfactory sensory neurons (OSNs), which are traditionally defined as mature by their expression of the olfactory marker protein (OMP). Mature OSNs differentiate in situ from stem cells at the base of the MOE. The consensus view is that mature OSNs have a defined lifespan and then undergo programmed cell death, and that the adult MOE maintains homeostasis by generating new mature OSNs from stem cells. But there is also evidence for mature OSNs that are long-lived. Thus far modern genetic tools have not been applied to quantify survival of a population of OSNs that are mature at a given point in time. Here, a genetic strategy was developed to label irreversibly OMP-expressing OSNs in mice. A gene-targeted OMP-CreERT2 strain was generated in which mature OSNs express an enzymatically inactive version of the Cre recombinase. The fusion protein CreERT2 becomes transiently active when exposed to tamoxifen, and in the presence of a Cre reporter in the genome such as tdRFP, CreERT2-expressing cells become irreversibly labeled. A cohort of mice was generated with the same day of birth by in vitro fertilization and embryo transfer, and injected tamoxifen in their mothers at E18.5 of gestation. I counted RFP immunoreactive cells in the MOE and vomeronasal organ of 36 tamoxifen-exposed OMP-CreERT2 × tdRFP mice from 7 age groups: postnatal day (PD)1.5, PD3.5, PD6.5, 3 weeks, 9 weeks, 6 months, and 12 months. Approximately 7.8% of perinatally labeled cells remain at 12 months, confirming that some mature OSNs are indeed long-lived. The survival curve of the population of perinatally labeled MOE cells can be modeled with a mean half-life of 26 days for the population as a whole, excluding the long-lived cells.
Introduction
The sense of smell informs an organism about the chemical composition of the external environment. The main olfactory epithelium (MOE) of an adult mouse harbors a few million olfactory sensory neurons (OSNs) expressing a large repertoire of odorant receptor (OR) genes (Buck and Axel, 1991) . A mature OSN is a bipolar neuron, with its single, short dendrite ending in cilia that protrude into the mucus covering the MOE, and its single, unbranched axon coursing from the nasal to the olfactory bulb. The cell body of the OSN resides within the MOE. The axon of an OSN terminates within one of~3600 glomeruli of the olfactory bulb (Richard et al., 2010) , where it makes synaptic contact with the dendrites of second-order neurons and interneurons in the olfactory pathway. OSNs are generated in situ from stem cells that are located at the base of the MOE -basal cells. OSNs are traditionally defined as mature by virtue of their expression of the olfactory marker protein (OMP) (Margolis, 1972) , a cytosolic protein with poorly understood function. OMP expression is first detectable in the mouse MOE at embryonic day (E)14 , and follows the expression of OR genes (Rodriguez-Gil et al., 2015) . In addition, mature cells are restricted to the upper half of the MOE, whereas immature cells are preferentially located in the lower half of the MOE (RodriguezGil et al., 2015) .
The MOE of unlesioned, unperturbed, and otherwise healthy adult mice appears to be in homeostasis: a status quo, a dynamic equilibrium between dying mature OSNs and newly generated mature OSNs. The consensus view is that the adult MOE produces constantly and regularly OSNs from stem cells throughout life, similarly to what occurs for instance in the epidermis of the skin and in the epithelium of the gastrointestinal and respiratory tracts. A mature OSN is thought to have a defined lifespan and then undergo programmed cell death. Environmental insults such as exposure to toxic substances or infectious agents can shorten OSN lifespan. The notion of a 30-day lifespan of OSNs in rats and mice continues to permeate the modern literature, but originates from a superficial interpretation (Mackay-Sim, 2003) of the original data (Moulton, 1975; Graziadei and Monti Graziadei, 1979) .
There have been challenges to the concept of a regular OSN turnover and a defined, relatively short lifespan (Hinds et al., 1984; Mackay-Sim and Kittel, 1991a) . In a first study (Hinds et al., 1984) , mice were housed in clean conditions of laminar flow, which presumably reduces their exposure to toxic and infectious agents. After a single injection of tritiated thymidine in mice 2 or 4 months of age, approximately 10% of labeled cells could be detected 6 to 12 months later. A caveat is that the tritiated thymidine could have been incorporated by cells that were dividing at the time of the injection but gave rise to mature OSNs much later (Mackay-Sim, 2003) . In a second study (Mackay-Sim and Kittel, 1991a) , a retrograde tracer was injected into the olfactory bulb of mice aged 12 weeks or more; these gold particles could be seen in the MOE even at the latest time point of 90 days. The data in the pioneering papers (Graziadei and Monti Graziadei, 1979; Mackay-Sim and Kittel, 1991a, 1991b) have been interpreted in terms of "a half-life of about 90 days" (Gogos et al., 2000) . A recent review mentions "an average lifespan of 3 months" (Magklara and Lomvardas, 2013) .
What are these estimates of lifespan: lower estimates, averages, or medians? Do the long-lived OSNs represent just a few outliers? What is the difference between lifespan and half-life? Rigorous quantification has been missing thus far. But it is intrinsically difficult to assess lifespan and half-life in a heterogeneous cell population such as the MOE, which consists of supporting cells, OSNs at various stages of differentiation, and basal cells. In turn, OSNs comprise~1087 distinct populations of cells, each expressing a different OR gene (Buck and Axel, 1991; Saraiva et al., 2015) . The number of OSNs that expresses a given OR gene varies enormously (Bressel et al., 2016) . Moreover the MOE is asynchronous in terms of proliferation, differentiation, and neurogenesis: there are cells at any stage of differentiation in a particular area of the MOE, and there is no evidence for waves of proliferation and differentiation. The traditional marker of mature OSNs, OMP, was not used in the pioneering literature (Moulton, 1975; Graziadei and Monti Graziadei, 1979; Hinds et al., 1984; Mackay-Sim and Kittel, 1991a, 1991b) , although OMP was then already known to be highly restricted to mature OSNs (Monti Graziadei et al., 1977) .
Here, a genetic strategy has been developed to label irreversibly mature, OMP-expressing OSNs around birth (perinatally). An OMP-Cre strain has previously been generated by gene targeting in embryonic stem (ES) cells (Li et al., 2004) . In this strain, mature OSNs express the site-specific Cre recombinase. By crossing the OMP-Cre strain with a Cre reporter strain, mature OSNs can be labeled irreversibly. I have now generated a complementary strain, OMP-CreERT2, by gene targeting in ES cells. Instead of a constitutively active Cre recombinase, an enzymatically inactive version of Cre recombinase is expressed in mature OSNs of OMP-CreERT2 mice. The fusion protein CreERT2 becomes transiently enzymatically active when exposed to tamoxifen, and in the presence of a Cre reporter gene in the genome, CreERT2-expressing cells are labeled permanently. CreERT2 thus allows for temporal control of the irreversible genetic labeling of cells that express the gene of interest at the time of tamoxifen exposure (Rodriguez-Gil et al., 2015) . I crossed the OMP-CreERT2 mice to tdRFP mice (Luche et al., 2007) , a well-established reporter strain for Cre/loxP recombination that displays no leakiness and affords irreversible expression of red fluorescent protein from the ubiquitously expressed ROSA26 locus. Due to ongoing death of mature OSNs and their replacement from precursors that do not express OMP, the RFP+ cells that were labeled perinatally are replaced gradually by RFP-cells: because there is no longer tamoxifen around, newly generated mature OSNs do not express enzymatically active CreERT2 and never activate the tdRFP reporter. The survival of the population of perinatally labeled MOE cells can be assessed by counting remaining numbers of RFP+ cells at various ages.
A cohort of mice with the same day of birth was generated by in vitro fertilization and embryo transfer into pseudopregnant wild-type recipient females. The resulting mice are heterozygous for OMPCreERT2 and heterozygous for the tdRFP reporter. Tamoxifen was injected in 5 pregnant recipients at E18.5, which gave birth to 55 offspring. I counted RFP immunoreactive cells in the MOE and vomeronasal organ (VNO) of 4 to 7 mice from 7 age groups, for a total of 36 mice: at postnatal day (PD)1.5, PD3.5, PD6.5, 3 weeks, 9 weeks, 6 months, and 12 months.
At 12 months, 7.8% of the number of RFP+ cells that were labeled at PD1.5 still survived: these are thus long-lived mature OSNs. The decline of the population of perinatally labeled cells in the MOE can be modeled with a mean half-life of 26 days. Interestingly, the population of OMP+ cells labeled perinatally in the vomeronasal organ (VNO) does not decline with age, suggesting that neurogenesis and homeostasis may follow different principles in the VNO and MOE.
Experimental methods

Generation of the OMP-CreERT2 mouse strain by gene targeting
To generate the pOMP-CreERT2-FNF targeting vector, the PacIflanked Cre-FNF cassette of pBS-OMP-CreFNF (Li et al., 2004 ; plasmid #15508, Add gene) was replaced by the PacI-flanked CreERT2-FNF cassette that I constructed from pCre-ERT2 (Feil et al., 1997 ; gift from Dr. Pierre Chambon, Illkirch, France). The 6 kb left homology arm contains the 5′UTR and the Omp start codon in exon 1. The 5.8 kb right homologous arm contains part of the 3′UTR of Omp. The targeting vector was linearized and electroporated into parental ES cell line E14 of genetic background 129P2/OlaHsd (Mombaerts et al., 1996) . Selection was with G418, and screening for homologous recombination by non-radioactive Southern blot hybridization of genomic DNA with a probe external to the targeting vector. Targeted ES cell clones were injected into C57BL/6J blastocysts, and chimeras were bred with ROSA-FLPe mice (The Jackson Laboratory, JR#3946) to remove the FRT-flanked neo-selectable marker, FNF. After Flp-mediated recombination, the Flp transgene was removed by breeding with C57BL/ 6J. The OMP-CreERT2 strain was established from ES clone C103.
The chimera C103 was crossed to a C57BL/6 female, which gave birth to a male heterozygous for OMP-CreERT2-FNF. Next the FNF cassette was removed by crossing OMP-CreERT2-FNF males with ROSAFLPe females, resulting in offspring heterozygous for OMP-CreERT2.
Primer sequences (genotyping): CZ40A: ctgcagttcgatcactggaac AB81: agggagctggttcacatgat 721A: aaaggcctctacagtctatag The OMP-CreERT2 strain is publicly available from The Jackson Laboratory in a mixed 129 × C57BL/6J background, as official strain name STOCK Omp < tm12.1(cre/ERT2)Mom > /MomJ and JR#18788. The td-RFP reporter strain was obtained from Dr. Hans Jörg Fehling (Ulm, Germany) (Luche et al., 2007) .
Mice were maintained in specified pathogen-free conditions in individually ventilated cages of the Tecniplast green line. They received ad libitum gamma-irradiated ssniff V1124-727 feed (snniff, Soest, Germany). Nesting, bedding, and enrichment were provided as nestpak, Datesand Grade 6 (Datesand, Manchester, UK). Mouse experiments were carried out in accordance with the German Animal Welfare Act, European Communities Council Directive 2010/63/EU, and the institutional ethical and animal welfare guidelines of the Max Planck Institute of Biophysics and the Max Planck Research Unit for Neurogenetics. Approval came from the Regierungspräsidium Darmstadt and the Veterinäramt of the City of Frankfurt.
Immunohistochemistry
Mice were anesthetized by injection of ketamine HCl and xylazine (210 mg/kg and 10 mg/kg body weight, respectively) and perfused with ice-cold PBS, followed by 4% PFA in PBS. The mouse heads were dissected, post-fixed in 4% PFA, and decalcified in 0.45 M EDTA in 1× PBS for one or two overnight periods at 4°C. Samples were cryoprotected in 15% and 30% sucrose in 1× PBS at 4°C overnight, respectively, and frozen in O.C.T. compound (Tissue-Tek). Serial coronal sections of 12 μm encompassing the SO, VNO and MOE were cut with a Leica CM3500 cryostat. Sections were washed with 1× PBS and subsequently blocked with 10% normal donkey serum, 0.1% Triton X-100 in 1× PBS for 1 h at room temperature. After the blocking step, sections were incubated in 5% BSA, 0.1% Triton X-100 in 1× PBS overnight at 4°C with the following primary antibodies: goat anti-Omp (1:400, Wako Chemicals #544-10001-WAKO), rabbit anti-Cre (1:250, Novagen #69050-3) and rabbit anti-DsRed (1:300, Clontech #632496). After incubation with primary antibodies, sections were incubated at 1.5 h at room temperature with secondary antibodies: donkey anti-goat IgG Cy5 (Jackson ImmunoResearch #705-175-147) for goat anti-Omp and donkey anti-rabbit IgG-Alexa 546 (Life Technologies #A10040) for rabbit anti-DsRed. Sections were washed and DAPI (1:10,000, Molecular Probes #D1306) was used for nuclear staining, followed by embedding in MOVIOL (Calbiochem #475904). Sections were analyzed with a Zeiss LSM 710 confocal microscope or scanned with a Aperio Scanscope FL as indicated.
In vitro fertilization and embryo transfer
These experiments were performed contractually at the AAALACaccredited animal facility of Charles River Laboratories (Lyon, France) according to Directive 2010/63/EU. Mice were housed under a 12 h dark-light cycle at 22 ± 3°C with ad libitum food and water. Female mice were used as oocyte donors at 4-7 weeks, and sperm donors at 10-20 weeks. Female mice were superovulated by two intraperitoneal injections 48 h apart: 5 IU eCG (Folligon, Intervet, France) and 5 IU hCG (Chorulon, Intervet) respectively. Cumulus-oocytes complexes and motile sperm were obtained 15-17 h after hCG injection. Gamete coincubation was conducted in vitro for 6 h at 37°C with 5% CO2. Oocytes were then rinsed in KSOM medium and incubated under paraffin oil overnight at 37°C with 5% CO2. Fertilized oocytes that had developed to the two-cell embryo stage were transferred through the wall of the Fallopian tube of 12-wk old OF1 or CD1 females on the day a vaginal plug was detected.
Induction by tamoxifen
Twenty milligram tamoxifen-free base (Sigma T5648) was dissolved in 100 μl corn oil for 1 h in a roller (hybridization oven) at 65°C. Females at E18.5 of gestation were injected intraperitoneally with 1 mg tamoxifen per 10 g body weight, and housed separately.
Cell counting
The offspring of the tamoxifen-injected pregnant females were weaned at 3 weeks, group-housed according to sex, never bred, aged, and analyzed at one of 7 ages. The entire MOE, SO, and VNO of each mouse was cryosectioned at 12 μm. Sections were stained immunohistochemically for RFP and scanned with an Aperio Scanscope FL. Each fluorescent cell body in each section was marked with a dot by the same observer and was counted automatically by the Aperio software. By scanning a slide with the red and the green filter, fluorescent cells could be clearly distinguished from background fluorescence. Since the nucleus was not always visible in the scans, a complete profile of a red-fluorescent cell body was counted, regardless of the presence of the nucleus (Suppl. 1).
Results
Generation of an OMP-CreERT2 mouse strain by gene targeting
I constructed an OMP-CreERT2 targeting vector according to the same design as the OMP-Cre targeting vector (Mombaerts et al., 1996; Li et al., 2004) (Fig. 1) . Out of 180 colonies of the ES cell line E14 screened, I identified 14 (7.8%) with the desired homologous recombination event. I obtained germline transmission of the OMPCreERT2 mutation from a chimera generated by injecting ES cells into a C57BL/6 blastocyst. The OMP-CreERT2 strain was established and maintained in a mixed 129 × C57BL/6 background, and is publicly available from The Jackson Laboratory. As the targeted mutation deletes the OMP coding region, it is prudent to use heterozygous instead of homozygous mice for experiments: mature OSNs in heterozygous mice still express OMP, albeit presumably half as much as in wild-type mice. Homozygous mice are subfertile but can be used for breeding. Fig. 2 shows immunohistochemical visualization of CreERT2 protein in coronal cryosections of the main olfactory mucosa of mice at postnatal day (PD)21, of three genotypes: C57BL/6J, OMP-Cre heterozygous, and OMP-CreERT2 heterozygous. There is OMP but no Cre immunoreactive signal in the MOE of the C57BL/6J mouse ( Fig. 2A) . In the MOE of the OMP-Cre and OMP-CreERT2 mice, OMP and Cre are coexpressed widely across the upper cell layers, which comprise mature OSNs. I observe the same patterns of OMP and Cre immunoreactivity in 
Immunohistochemistry of the MOE and VNO for OMP and Cre
Tamoxifen induction of CreERT2 in OMP-expressing cells activates an RFP reporter
Next, a genetic strategy was developed to label irreversibly a population of cells expressing OMP at a given point, and to follow the decay of the labeled population with time.
The estrogen receptor ligand-binding domain of the CreERT2 fusion protein has been mutated to no longer bind estrogen but to bind tamoxifen or its metabolite 4-hydroxytamoxifen (Feil et al., 1997) . Upon injection of tamoxifen in the mouse, cells that express CreERT2 at that time will transiently display enzymatic Cre activity, until tamoxifen is cleared from the body. Tamoxifen-induced enzymatic activation of CreERT2 can be harnessed to label irreversibly cells that express CreERT2 from a transgene or gene-targeted mutation, by crossing CreERT2-expressing mice to a Cre-reporter mouse strain. The Cre-reporter strain tdRFP (Luche et al., 2007) has been designed specifically to avoid leakiness in reporter expression by employing two incompatible pairs of loxP sites and an inversion strategy (Fig. 3A) . A tandem dimer RFP (tdRFP) variant is generated from the ubiquitously expressed ROSA26 locus.
Injection of tamoxifen into mice of a cross of the OMP-CreERT2 and tdRFP strains transiently renders CreERT2 enzymatically active in cells that express OMP at that time, thus in mature OSNs (Fig. 3B ) and in mature VSNs. Activation of CreERT2 results in RFP expression from the ROSA26 locus for the remainder of the lifespan of the mature OSN. Fig. 3C illustrates the occurrence of RFP+ cells spread widely and evenly across the MOE of a PD0.5 mouse heterozygous for OMPCreERT2 and heterozygous for tdRFP, after tamoxifen was administrated to its mother at E18.5 of gestation.
In the MOE (Fig. 4A) and VNO (Fig. 4B ) of OMP-CreERT2 × tdRFP embryos at E18.5 that had not been exposed to tamoxifen, there are no RFP+ cells at all, confirming that there is no leaky expression of the reporter in the absence of tamoxifen and demonstrating also that there is no background RFP immunoreactivity in this tissue with my staining protocol. By contrast, OMP-Cre × tdRFP embryos at E18.5 harbor an abundance of RFP+ cells, in a similar pattern as OMP+ cells. Furthermore, the absence of leaky expression was confirmed in mice up to 9 weeks (data not shown).
Taken together, in the OMP-CreERT2 × tdRFP cross, OMP+ cells can be induced to express RFP by tamoxifen exposure at E18.5, without leakiness and without background signal.
Tamoxifen induction in a cohort of mice generated by in vitro fertilization (IVF)
The logistics of mouse breeding by natural matings is such that it is difficult to generate a large cohort of mice with the same day of birth, which would be optimal for the experimental design of a time course. I therefore resorted to in vitro fertilization (IVF) and embryo transfer. Sperm was obtained from males homozygous for the OMP-CreERT2 and tdRFP2 mutations, and oocytes from superovulated wild-type C57BL/6 females. The embryos generated by IVF are thus heterozygous for OMPCreERT2 and tdRFP. These embryos were transferred into pseudopregnant wild-type recipients. Five pregnant females were injected at E18.5 of gestation with 1 mg tamoxifen per 10 g body weight, and then single-housed. A total of 55 offspring were born by natural vaginal delivery two days postinjection. The offspring were group-housed according to sex, never bred, and aged for up to 12 months. I perfused 36 mice from 7 age groups of this cohort: PD1.5 (n = 4 mice), PD3.5 (n = 5), PD6.5 (n = 5), 3 weeks (n = 4), 9 weeks (n = 5), 6 months (n = 6), and 12 months (n = 7). I stained 12 μm cryosections of the nasal cavity with an RFP antibody to enhance the signal.
I took a "count every cell" strategy (Bressel et al., 2016) , counting all labeled cell profiles on all serial coronal sections. The difference with Bressel et al., 2016 is that I counted labeled cells not live under a confocal microscope, but posthoc on digital scans of the histological slides produced with an Aperio Scanscope FL. I thus produced permanent electronic copies of the samples in their entirety, enabling the recounting of sections or slides if necessary. Another experimental advantage of digital scans is the ability to distinguish readily cells that express the fluorescent dye from cells or spots that are autofluorescent. The filter set for green dyes was used in combination with the red filter set. The color of the filter set used for tdRFP/A546 was set to "red", and the color of the filter set for green dyes was set to "green". Autofluorescence was detected by both filter sets and thus appears yellow when overlapping the channels, whereas cells that express the fluorescent dye appear bright red and not green (Fig. 5A) .
Since a labeled OSN that is cut in half and split over two consecutive sections might be counted twice, the raw cell counts represent an overestimation of the true OSN numbers. In order to obtain better estimates of the true numbers of labeled cells, I applied the Abercrombie correction on cell counts (Correction factor = Section thickness/(Cell diameter + Section thickness): Abercrombie, 1946) . I measured the diameter of sets of labeled cells in the MOE (Fig. 5B) and VNO (Fig. 5C ) of the 7 age groups. The average sizes for the OSN cell bodies are 5-5.5 μm, without significant differences among the 7 age groups (oneway ANOVA, F = 5.75, P = 0.32). In the VNO, the diameter of VSN cell bodies is 6-7 μm at the younger stages (PD1.5-PD6.5) and increases to nearly 10 μm in older mice (12 months); however, these differences are not statistically significant (one-way ANOVA, F = 20.78, P = 0.093). I calculated an Abercrombie correction factor that is specific for the MOE or the VNO for each of the 7 age groups, thus 14 correction factors in total. For the septal organ (SO), in which labeled cells are sparse, I used the correction factors from the MOE. I annotated labeled cells individually on the digital scans one by one (Fig. 5D ), ensuring that each labeled cell is counted, and is counted only once. The Aperio software enumerates automatically the cells that have been annotated by the observer. This annotation makes the cell counts more robust, from young to aged mice. In young mice, there is an abundance of labeled cells, which are often densely packed, requiring a reliable method to keep track of counted cells. In aged mice, there are fewer labeled cells but the MOE increases dramatically in size such that it becomes difficult with a conventional microscope to keep track of areas in the MOE where cells have been counted already.
Survival curve of mature OSNs labeled genetically perinatally
I weighed the mice in the 7 age groups prior to perfusion (Fig. 6A ). There is relative little variation among mice of a given age group, and the mice thrived. None of the offspring of the tamoxifen-injected Fig. 2 . Immunohistochemistry of the MOE and VNO for OMP and Cre. Cre protein expression in a heterozygous OMP-CreERT2 mouse was visualized immunohistochemically at PD21, in comparison with a heterozygous OMP-Cre mouse (positive control) and a C57BL6/J mouse (negative control) of the same age. An antibody against Cre (A488, red) was used in combination with an antibody against OMP (Cy5, green), to localize expression of CreERT2 and OMP. (A) MOE, (B) VNO. Scale bar, 100 μm.
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pregnant recipients showed health problems or died spontaneously. In the MOE, the Abercrombie-corrected cell numbers started off at 15.000 in the youngest age group, PD1.5 (Fig. 6B) . The cell numbers at PD1.5 (14,741 ± 6109), at PD3.5 (12,226 ± 6286), at PD6.5 (14,787 ± 3080), and at 3 weeks (9789 ± 4704) do not show statistically significant differences in all six pairwise comparisons (PD1.5 to PD3.5, t-test, P = 0.5651; PD1.5 to PD6.5, P = 0.9888; PD1.5 to 3 weeks, P = 0.2463; PD3.5 to PD6.5, P = 0.4371; PD3.5 to 3 weeks, P = 0.5416; PD6.5 to 3 weeks, P = 0.0950). At 9 weeks, the cell number (3941 ± 1644) is significantly lower than at 3 weeks (t-test, P = 0.034) and even more significantly lower than at PD6.5 (P = 0.0001). The cell number at 6 months (1896 ± 754) is significantly lower than at 3 weeks (P = 0.0032) and at 9 weeks (P = 0.0228). At 12 months (1165 ± 290), the cell number is decreased to its lowest, with significant differences compared to 3 weeks (P = 0.0007), 9 weeks (P = 0.0012), and 6 months (P = 0.0364). The differences between the counts in the age groups are statistically highly significant (one-way ANOVA, F = 14.19, P < 0.0001). The coefficient of variation (standard deviation/mean) was computed for all ages: the CV is 0.41 at PD1.5; 0.51 at PD3.5; 0.21 at PD6.5; 0.48 at 3 weeks; 0.42 (A) Mice from the OMP-CreERT2 strain were crossed to the Cre-reporter strain tdRFP. The tandem dimer2 RFP (tdRFP) variant is integrated at the ROSA26 locus in reverse orientation relative to ROSA26 transcription. The wild-type loxP and mutant loxP2272 mutant sites are incompatible with one another in the Cre recombination reaction. Based on the position and orientation of these pairs, Cre-mediated recombination induces first an inversion of the flanked sequences at either the loxP or loxP2272 sites, followed by irreversible excision of the neomycin STOP segment along with its neighboring loxP2272 or loxP site, respectively. (B) Injection of tamoxifen into an OMP-CreERT2 × tdRFP mouse transiently renders CreERT2 enzymatically active in OMP+ cells, which are mature OSNs (mOSNs), but not in immature OSNs (iOSNs), which are GAP43+ but do not express OMP. CreERT2 then catalyzes the site-specific recombination in the tdRFP reporter, initiating constitutive RFP expression from the ROSA26 promoter. With time, the RFP+ cells will be replaced by newly generated, mature OSNs that do not express RFP. (C) Immunohistochemical staining of RFP (A546, red) in a mouse that is heterozygous for OMP-CreERT2 and heterozygous for tdRFP strain. Tamoxifen (1 mg per 10 g body weight) was administered to the pregnant mother at E18.5 of gestation, and the MOE of one of her pups was analyzed at PD0.5. The induced, RFP+ cells are scattered evenly across the whole MOE. Scale bars: upper panel, Aperio, 100 μm; lower panel, confocal microscope, 50 μm.
at 9 weeks; 0.40 at 6 months; and 0.25 at 12 months. There are thus large no age-related differences in CV. I did not observe any labeled cells in embryos at E18.5 that were not exposed to tamoxifen (Fig. 6B) , demonstrating the absence of leakiness of the reporter and of background RFP immunoreactivity. Fig. 6C plots the Abercrombie-corrected cell numbers compared to PD6.5, the age group in which I counted the highest average number of labeled cells. The cell numbers decrease with time, and 7.8% of perinatally labeled cells remain at 12 months. The survival curve was modeled with a starting number A, a half-life B, and a constant number C of "eternally living" cells: #cells(days) = A * exp(−ln(2) * days/ B) + C. The first two data points (PD1.5 and PD3.5) were removed as the cell numbers are similar to PD6.5. This function then fits very well to the data (R 2 = 0.995), with best-fit parameter values 15,740 ± 4022 cells for A, 26.3 ± 10.3 days for B, and 1235 ± 277 cells for C. Thus, the population of perinatally labeled MOE cells has a mean half-life of 26 days.
Survival curve of mature OSNs in the septal organ and of VSNs
The septal organ (SO) is an outpost of the MOE at each side of the nasal septum (Fig. 7A) . The Abercrombie-corrected number of induced cells is~60 in the SO at PD1.5, PD3.5 and PD6.5 (Fig. 7C) . The number at 3 weeks (27.09 ± 15.47) shows a significant decrease compared to PD6.5 (t-test, P = 0.0063). At 9 weeks (5.21 ± 4.13), the number is decreased significantly compared to PD6.5 (P < 0.0001) and to 3 weeks (P = 0.0179). The number at 6 months is not significantly different from the number at 9 weeks (P = 0.36), but significantly lower compared to 3 weeks (t-test, P = 0.0056). At 12 months (0.76 ± 71) nearly no labeled cells remain in the SO. The differences between the various age groups are statistically highly significant (oneway ANOVA, F = 10.38, P < 0.0001).
Finally, I counted labeled cells in the VNO (Fig. 7B) . Surprisingly, the Abercrombie-corrected number of labeled cells in the VNO remains at~140 for each age group. The numbers do not differ significantly between age groups (one-way ANOVA, F = 1.469, P = 0.2237), indicating that most cells that were labeled genetically perinatally survived for 12 months.
Discussion
A genetic strategy for assessing survival of mature OSNs
I here report a genetic strategy to label a population of mature OSNs irreversibly, based on the widely used paradigm of permanent cell labeling with a tamoxifen-inducible Cre recombinase and a Cre reporter gene (Feil et al., 1997; Luche et al., 2007; Rodriguez-Gil et al., 2015) . This labeling strategy resembles a classical pulse-chase experiment in biochemistry, with the difference that cells, not molecules, are being tracked. A cohort of mice with the same day of birth was generated by Fig. 4 . Immunohistochemistry of the MOE and VNO for RFP and OMP. (A) Immunohistochemical staining for RFP (A546, red) and OMP (Cy5, green) in the MOE of E18.5 embryos that are either heterozygous for OMP-CreERT2 and homozygous for tdRFP, or heterozygous for OMPCre and homozygous for tdRFP. No RFP fluorescence is detected in the MOE of the OMP-CreERT2 × tdRFP embryo in the absence of tamoxifen, whereas OMP+ cells were found scattered across the MOE. CreERT2 shows thus no leaky activation of the reporter. RFP fluorescence is detected in the MOE of the OMPCre × tdRFP embryo, and the RFP expression pattern correlates with the OMP expression pattern. Scale bar, 50 μm. (B) Similar findings were made in the VNO as for the MOE. Scale bar, 50 μm.
in vitro fertilization and embryo transfer, and injected tamoxifen in their mothers at E18.5 of gestation. Thus, populations of cells that expressed the Omp locus around the time of birth (perinatally) were labeled. I took a "count every cell" strategy, counting all labeled cell body profiles in all sections from digital scans of the histological sides. The main finding is that the population of MOE cells that was labeled perinatally can be modeled with a mean half-life of 26 days for the population as a whole. Approximately 7.8% of perinatally labeled cells remain in the MOE at 12 months, confirming that some mature OSNs are indeed long-lived. Surprisingly, the numbers of labeled cells in the VNO remain constant from birth to 12 months. The OMP-CreERT2 strain is publicly available from The Jackson Laboratory, and will be useful for similar labeling experiments conducted at later ages such as in adult mice. 
Lifespan of an individual OSN vs the whole population
Fifty years ago the proposal was made that the olfactory epithelium, in particular its sensory neurons, undergoes a "ständige Regeneration" (continuous regeneration) in experimentally unperturbed mammalsrats, cats, and dogs (Andres, 1965 (Andres, , 1966 . The concept of a 30-day lifespan for OSNs emerged from a limited number of studies in mice (Moulton, 1975; Graziadei and Monti Graziadei, 1979) . This early estimate, which continues to permeate the literature, was based on two rudimentary methods. The numbers of cells blocked in metaphase 5 h vs 3 h after injection of the mitosis-blocking chemical colchicin yielded a turnover time of the entire population of 28.6 ± 6.6 days, which was interpreted as the turnover time of the OSNs (Moulton, 1975) . Autoradiography after injection of tritiated thymidine, which is incorporated during DNA synthesis and labels nuclei but gets diluted with successive cell divisions, led to the interpretation that basal cells differentiate into OSNs in approximately 9 days and that these OSNs then remain in the MOE as mature functional elements for approximately 25 days (Graziadei and Monti Graziadei, 1979) . The view of a regular turnover of the MOE with a defined lifespan of OSNs was challenged when evidence indicated that some OSNs are long-lived (Hinds et al., 1984; Mackay-Sim and Kittel, 1991a, 1991b) None of these studies relied on the traditional marker for mature OSNs, OMP (Margolis, 1972) , although it had been known for a while that OMP is highly restricted to mature OSNs (Monti Graziadei et al., 1980) . More recently, OSNs have been said to have a "half-life of about 90 days" (Gogos et al., 2000) , or an "average lifespan of 3 months", which corresponds to 90 days (Magklara and Lomvardas, 2013) . It is obvious that there must be a substantial degree of heterogeneity of lifespan among OSNs. Reliable estimates of average lifespan or half-life are difficult to make based on the available evidence. The MOE does not regenerate synchronously in waves, and an early study mentioned already the distinction between active vs quiescent regions in the MOE (Graziadei and Monti Graziadei, 1979) . With 1087 of the 1099 intact OR genes expressed in mature, OMP+ OSNs (Saraiva et al., 2015) , OSNs are extraordinarily heterogeneous merely on the basis of the expressed OR gene. Some OR genes are expressed in many more OSNs than others (Bressel et al., 2016) .
Furthermore, neuronal activity is critical for OSN development and survival. The manipulation of odorant exposure can lead to an altered OR gene expression. In fact, it has been shown that unilateral naris closure leads to differential effects in OSNs expressing different OR genes. Depending on the OR gene, expression in the sensory-deprived side was significantly lower, similar, or significantly higher compared to the over-stimulated side (Zhao et al., 2013) .
Thus, the established median half-life of 26 days for OSNs in mice maintained in specified pathogen-free conditions may vary considerably from sensory-deprived or over-stimulated mice. The best one can do with currently available mouse strains and methods, is to determine the half-life for a labeled population as a whole. The survival curve of the Abercrombie-corrected counts of cells that were labeled perinatally has been modeled, it was found that this population decreases by half approximately every 26 days between PD6.5 (the highest number of labeled cells, to which numbers at successive ages were compared) and 12 months, including a remaining subpopulation of long-lived OSNs. But a half-life of an extremely heterogeneous population of 26 days cannot be converted to a half-life of individual OSNs, neither into a lifespan. I believe that it is a coincidence that number of 26 days that I determined is similar to the estimate of 30 days in the earlier studies (Moulton, 1975; Graziadei and Monti Graziadei, 1979) .
Pioneer neurons?
At 12 months, approximately 7.8% of labeled cells survive in the MOE, indicating that there are some long-lived OSNs. What are these cells? Are they merely outliers on a wide spectrum of lifespan? Do these OSNs express a subset of the OR gene repertoire? Are these OSNs that have been activated on a regular basis by a cognate odorant and in a critical rhythm, thus prolonging their lifespan repeatedly? Or, conversely, are these OSNs for which the ambient environment of the mouse cage and the animal facility does not contain many ligands, thereby protecting these cells from overstimulation? These questions can be addressed by determining if a subset of the OR gene repertoire is expressed in these survivors, by single-cell RT-PCR (Malnic et al., 1999) , NanoString analysis (Khan et al., 2011 (Khan et al., , 2013 , or RNA-seq (Hachate et al., 2015; Saraiva et al., 2015; Tan et al., 2015) , from flowcytometrically sorted pools of RFP+ cells or from individually picked RFP+ cells. As a glomerulus corresponds to a particular OR (Mombaerts et al., 1996; Mombaerts, 2006) , a predominant innervation of certain glomeruli could be indicative of expression of a such a subset of OR genes. But the tdRFP reporter is not a great axonal marker: it does not lend itself well to visualizing OSNs axons terminating in glomeruli. Crossing OMP-CreERT2 to a Cre reporter that is a better axonal marker, such as tau-β-galactosidase (Mombaerts et al., 1996) , may be a solution.
Another possibility is that the labeled cells represent a population of pioneer neurons, which set up the axonal projections of OSNs onto thousands of glomeruli (Mombaerts, 2006) and are much more resistant to apoptosis. Tamoxifen induction at later stages, in particular in adult mice, will enable to address the question if such long-lived OSNs are born predominantly at early stages. It is remarkable that the approximately 7.8% of perinatally labeled cells surviving at 12 months is similar to the fraction of cells labeled by tritiated thymidine in mice aged 2 months or 4 months and surviving 6 to 12 months (Hinds et al., 1984) . Surprisingly, I found that the number of labeled cells in the VNO, although low, remains constant throughout the window of time I studied. It is possible that all OMP-expressing cells in the VNO that are present around birth, are special in terms of lifespan. A caveat for both the MOE Fig. 5 . Counting cells in the MOE and VNO of taxomifen-induced OMP-CreERT2 × tdRFP mice. (A) 12 μm cryosection of the MOE. The intrinsic fluorescence signal of tdRFP was enhanced by antibody staining (A546), followed by digital scanning with an Aperio Scanscope FL. The filter set for green dyes was used in combination with the red filter set. The color of the filter set used for tdRFP/A546 was set to red, while the color of the filter set for green dyes was set to green. Autofluorescence of cells or spots is detected by both filter sets and appears yellow when overlapping the channels, whereas cells that express the fluorescent dye appear bright red and not green. (B) Diameter of labeled OSN cell bodies in the MOE in the 7 age groups, from PD1.5 to 12 months. Since the nucleus was not always visible, the whole cell body was measured parallel to the surface of the MOE. Diameters show no significant differences among the 7 age groups. The diameter is 4.96 μm ± 0.88 at PD1.5; 4.83 μm ± 0.87 at PD3.5; 5.23 μm ± 0.87 at PD6.5; 5.06 μm ± 0.67 at 3 weeks; 5.51 μm ± 1.05 at 9 weeks; 5.63 μm ± 0.94 at 6 months and 5.97 μm ± 0.91 at 12 months. (C) Diameter of labeled VSN cell bodies in the 7 age groups, from PD1.5 to 12 months. The whole cell body was measured parallel to the surface of the VNO epithelium. Diameters show no significant differences among the 7 age groups. The diameter is 5.59 μm ± 1.71 at PD1.5; 5.82 μm ± 1.31 at PD3.5; 7.39 μm ± 1.44 at PD6.5; 8.42 μm ± 1.82 at 3 weeks; 9.03 μm ± 2.02 at 9 weeks; 8.60 μm ± 1.26 at 6 months and 9.97 μm ± 1.93 at 12 months. (D) Overview (left) and details of an unannotated (right top) and annotated (right bottom) part of the MOE from a PD6.5 mouse that is heterozygous for OMP-CreERT2 and heterozygous for tdRFP. Immunohistochemistry for RFP (A546). When the observer marks cells individually and manually, the numbers are counted automatically by the Aperio system. Scale bar: 500 μm, left; 100 μm, right. and the VNO is that it is not known if the fraction of cells that are labeled by tamoxifen induction of CreERT2 and activation of the tdRFP reporter is representative of the population as a whole.
A look ahead
It will be interesting to apply the CreERT2 labeling paradigm to OSNs that express a particular OR, specifically an OR that is well studied and for which odorous ligands are known. The extreme cellular heterogeneity of OMP-expressing cells can then be reduced to one of its 1087 constituent populations and the effects of odorant exposure on OSN survival can be studied as well. The CreERT2 labeling paradigm would best be applied to an OR gene that is expressed in many OSNs, in order to obtain sufficient numbers of labeled cells.
Supplementary data to this article can be found online at https:// doi.org/10.1016/j.mcn.2018.02.005. (A) Body weight of offspring that are heterozygous for OMP-CreERT2 and heterozygous for tdRFP after tamoxifen injection in their mothers at E18.5 of gestation. The body weight is 1.78 g ± 0.32 at PD1.5; 2.46 g ± 0.31 at PD3.5; 3.57 g ± 0.27 at PD6.5; 10.16 g ± 0.88 at 3 weeks; 23.89 g ± 2.05 at 9 weeks; 39.91 g ± 4.50 at 6 months and 46.49 g ± 5.14 at 12 months. (B) Numbers of RFP+ cells in the MOE after Abercrombie correction. The cell numbers are 14,741 ± 6109 at PD1.5; 12,226 ± 6286 PD3.5; 14,787 ± 3080 at PD6.5; 9789 ± 4704 at 3 weeks; 3941 ± 1644 at 9 weeks; 1896 ± 754 at 6 months and 1165 ± 291 at 12 months. Each square represents the number of labeled cells counted in the MOE of a single mouse. The Abercrombie correction factor was calculated (Correction factor = Section thickness/(Cell diameter + Section thickness). Subsequently, the corrected cell number was determined by multiplying the total cell counts by the correction factor. Uninjected pups at E18.5 (first point on the x-axis) were used as negative control. (C) Labeled cells expressed as percentages compared to the number at PD6.5, the age group in which I counted the highest average number of labeled cells and theoretical half-life of 26 days for OSNs according to the function: #cells(days) = A * exp(−ln(2) * days/B) + C (A = starting number, B = half-life, C = constant number of "eternally living" cells). The first two data points (PD1.5 and PD3.5) were removed for the modeling of the survival curve.
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